These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 899943)

  • 21. Serum parathyroid hormone levels and renal handling of phosphorus in patients with chronic renal disease.
    Popovtzer MM; Pinggera WF; Hutt MP; Robinette J; Halgrimson CG; Starzl TE
    J Clin Endocrinol Metab; 1972 Aug; 35(2):213-8. PubMed ID: 4672382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical effects of 25-hydroxycholecalciferol in patients with chronic renal failure.
    Matsushita Y; Hasegawa K; Otomo S; Morii H; Okamoto T
    J Nutr Sci Vitaminol (Tokyo); 1977; 23(3):257-61. PubMed ID: 915557
    [No Abstract]   [Full Text] [Related]  

  • 23. 1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; de Luca HF
    Proc Eur Dial Transplant Assoc; 1976; 12():227-36. PubMed ID: 935115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide.
    Verberckmoes R; Bouillon R; Krempien B
    Ann Intern Med; 1975 Apr; 82(4):529-33. PubMed ID: 1119767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical estimation of 1-alpha-hydroxycholecalciferol in treatment of patients with chronic renal failure].
    Chodorowski Z; Rutkowski B; Wielgosz A; Chamienia A; Sulima-Gillow A; Manitius A
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1093-5. PubMed ID: 1305733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
    Ahmed KY; Varghese Z; Meinhard EA; Baillod RA; Skinner RK; Wills MR; Moorhead JF
    Adv Exp Med Biol; 1977; 81():581-90. PubMed ID: 899942
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium carbonate. A better phosphate binder than aluminum hydroxide.
    Lerner A; Kramer M; Goldstein S; Caruana R; Epstein S; Raja R
    ASAIO Trans; 1986; 32(1):315-8. PubMed ID: 3535845
    [No Abstract]   [Full Text] [Related]  

  • 28. 1-alpha-hydroxycholecalciferol for renal osteodystrophy.
    Brownjohn AM; Goodwin FJ; Hately W; Marsh FP; O'Riordan JL; Papapoulos SE
    Br Med J; 1977 Sep; 2(6089):721-3. PubMed ID: 912269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of aluminium hydroxide on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure.
    Clarkson EM; Luck VA; Hynson WV; Bailey RR; Eastwood JB; Woodhead JS; Clements VR; O'Riordan JL; De Wardener HE
    Clin Sci; 1972 Oct; 43(4):519-31. PubMed ID: 4653591
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
    Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
    Hill AV; Thein-Than ; Cook DB; Derr KN; Latner AL
    Clin Nephrol; 1973; 1(5):284-9. PubMed ID: 4797465
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of 1-alpha-hydroxycholecalciferol (1 alpha-OH/D3) and 24,25-dihydroxycholecalciferol (24, 25-OH)2D3) on calcium and phosphorus metabolism in chronic renal failure].
    Galus K; Szymendera J; Jelińska S; Schabowska M; Jelonek A
    Pol Arch Med Wewn; 1979 Feb; 61(2):105-12. PubMed ID: 440977
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic effects of 1alpha-hydroxycholecalciferol on renal osteodystrophy.
    Castells S; Shai F; Gauthier B; Hashemi SE; Reddy CM; De Luca HF
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):410-9. PubMed ID: 817872
    [No Abstract]   [Full Text] [Related]  

  • 34. Biologic and therapeutic effects of 1 alpha-hydroxycholecalciferol in different types of Fanconi syndrome.
    Kitagawa T; Akatsuka A; Owada M; Mano T
    Contrib Nephrol; 1980; 22():107-19. PubMed ID: 6893175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-alphahydroxycholecalciferol in chronic renal failure. Studies of the effect or oral doses.
    Davie MW; Chalmers TM; Hunter JO; Pelc B; Kodicek E
    Ann Intern Med; 1976 Mar; 84(3):281-5. PubMed ID: 1259263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Kidney Int Suppl; 1983 Dec; 16():S171-4. PubMed ID: 6588249
    [No Abstract]   [Full Text] [Related]  

  • 37. Phosphate binders in hyperphosphatemia of chronic renal failure.
    Wasan SM; Godley PJ
    DICP; 1991 Sep; 25(9):942-5. PubMed ID: 1949972
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma 25-hydroxycholecalciferol in chronic renal failure.
    Bayard F; Bec P; Ton That H; Louvet JP
    Eur J Clin Invest; 1973 Dec; 3(6):447-50. PubMed ID: 4778374
    [No Abstract]   [Full Text] [Related]  

  • 39. Absorption of calcium, magnesium and phosphate during chronic renal failure and the effect of vitamin D in rabbits.
    Tvedegaard E
    Z Versuchstierkd; 1985; 27(3-4):163-8. PubMed ID: 4050164
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of 1alpha-hydroxyvitamin D3 in patients with chronic renal failure, with particular emphasis on the renal handling of phosphate.
    Madsen S; Olgaard K
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():85s-89s. PubMed ID: 606430
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.